Clinical Study on rapid-acting insulin analog in intensive basal and bolus insulin therapy - Efficacy and safety of glulisine-based multiple daily injection therapy in Japanese diabetic patients

Trial Profile

Clinical Study on rapid-acting insulin analog in intensive basal and bolus insulin therapy - Efficacy and safety of glulisine-based multiple daily injection therapy in Japanese diabetic patients

Completed
Phase of Trial: Phase III

Latest Information Update: 16 May 2013

At a glance

  • Drugs Insulin glulisine (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Adverse reactions; Biomarker; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 16 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top